RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

I'm leaning more towards private equity, as there seems to be little interest in bringing new drugs to market in today's neuropharma market.
Strike that.
I should say little interest in spending precious cash reserves in bringing new drugs to market. All agree that for many epidemic proportion afflictions there is little or no viable treatment: ADHD, Parkinsons, Alzheimers, etc. Yet pharma expenditures on investigational drugs, and partnering remain low compared to the potential market, and low in comparison to three to five years ago.
There is an old adage that the market can remain irrational longer than you can remain solvent.
I think that is poor old CORX's conundrum.
A well heeled private equity group with connections to pharma (perhaps a former CFO, or CEO), or maybe a wealth fund with a shopping list of discounted technology, might be the more likely purchaser, but at a much lower price than current market cap. As I've said before, I don't believe CORX is quite bite sized yet. Another stock offering and 12 to 16 more months of capitol burn will most likely make it so.